In animals, the central clock that keeps track of night and day is in the brain where it receives light from the retina to keep synchronized with the light or dark. But all cells in the body have their own clocks. Because these biological clocks have a cycle that is close to 24 hours they are termed circadian (“circa” meaning “about” and dian, meaning day, from the Latin “dies”.) We now live with cheap, bright, artificial light, shift-work, sleep-deprivation, and jet-lag – all major challenges to the ancient circadian control mechanisms in our bodies. All these circadian and sleep challenges are associated with disease. But in our latest study, using mice, we discovered that infections at different times of the day cause different severity of disease. Surprisingly, we found that the clock ticking in the cells of the immune system was responsible for the change in response to bacterial infection. In particular, specialized cells called macrophages, which are big cells that engulf and kill bacteria. Macrophages, either growing in a dish or in a mouse, responded differently at different times of the day. And disabling the clock in these cells resulted in super macrophages, which moved faster and ate more bacteria than the normal macrophages. We found that “clockless” macrophages protected mice from bacterial infection with many types of bacteria. A closer look at the macrophages revealed that the cells looked different, with a major change in the structural proteins that maintain the cell shape and are needed for cell movement and for eating bacteria. The change in the cell’s internal architecture, or cytoskeleton, became a focus of our studies. We discovered that the macrophage circadian clock directly controlled the components of the cytoskeleton. We saw changes in the amount of cytoskeletal protein building blocks, and also in the activity of a master regulator of cytoskeletal change. This master regulator is a protein called RhoA. RhoA is activated by bacterial contact and drives the macrophage to move and consume bacteria. We found that RhoA was active in the clockless macrophages even when no bacteria were present. When bacteria contacted the normal macrophages RhoA became active, but there was no further change in the clockless macrophages, as the RhoA was already active. So the clockless macrophages were always switched on, and so able to respond to bacterial attack more rapidly. To find out how the clock was changing the behaviour of macrophages, we turned to the core clock mechanism. This comprises a small group of proteins that change in abundance through time, so allowing the cells to tell the time. We found that one of these clock factors, called BMAL1, was the essential link between the clock and the macrophage behaviour.
Reducing reliance on antibiotics
One of the major issues facing the modern world is the growing resistance of bacteria to antibiotics. There have been no new classes of antibiotics for 30 years. Bacterial resistance to antibiotics means that we have untreatable infections and face a future where surgery will become riskier. Finding new ways to enhance defence against bacteria is a high priority. Discovery of a circuit linking the clock to bacterial defence opens up a new route to reduce our reliance of the limited range of existing antibiotics. It may be possible to enhance natural defences to bacterial infection by targeting the clock. The operation of the circadian clock can be altered by light exposure, by changing meal times, by genetic variability within human populations and by new drugs capable of regulating this system. One problem with targeting the clock with drugs is that the impact on other systems will be broad and the consequences hard to predict. But short-term intervention to boost immunity to infection may offer benefits, at low cost. Similarly, reinforcing the circadian rhythm of high-risk people, in hospitals for example, by controlling lighting and meal times may boost immunity and prevent hospital-acquired infections. This article is republished from The Conversation by David Ray, Professor of Endocrinology, University of Oxford and Gareth Kitchen, Academic Clinical Lecturer and Anaesthetist, University of Manchester under a Creative Commons license. Read the original article.
